MANILA (Reuters) - Philippine public officials showed "reckless disregard of processes" in carrying out a programme to immunise hundreds of thousands of children, a senator leading an investigation into the government's use of a new dengue vaccine said on Monday.
On Dec. 1, the Philippines halted use of Dengvaxia after its maker, French drug firm Sanofi said the vaccine itself might, in some cases, increase the risk of severe dengue in recipients not previously infected by the virus.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
